Marinova Pty Ltd Pure Source - Pure Science
Marinova is an Australian biotechnology company which produces a range of innovative seaweed extracts for nutritional, cosmetic and biopharmaceutical applications. Marinova are the world experts in developing chemically consistent organic fucoidan extracts with proven clinical efficacy.
Number of employees: 20
Main business focus/
Listing by sector:
- AgBio - Plant
- Regenerative & Stem Cells
Marinova has ISO9001 accreditation across all its operations, HACCP accreditation as well as Organic, Kosher and HALAL certification and can produce under GMP condition. Marinova has also the ability to produce fucoidan extracts that meet FDA and European pharmaceutical standards. Marinova’s modular technology platform allows the production of characterised fucoidan extracts from various seaweeds, ensuring Marinova can meet the various requirements of different customers and product applications.
The company has a unique proprietary solvent-free extraction process which produces organic fucoidan extracts that remain unadulterated in chemical structure and free from solvent residues. Marinova has developed a library of fucoidan extracts, and can isolate patentable fractions as active ingredients for pharmaceutical or medical device products.
Marinova has a number of strategic partnerships with a diverse range of research organisations and both pharmaceutical and nutraceutical companies. We have a close partnership with University of Tasmania and Royal Hobart Hospital for clinical trials.
Marinova seeks partnerships with pharmaceutical companies with an interest in developing fucoidan APIs, and with nutraceutical and cosmetic companies looking for organic-certified fucoidan ingredients with clinically proven efficacy.
Capital for clinical trials
|Contact person||Kevin Krail|
|Job Title||Business Development Manager|
|Address||249 Kennedy Drive|
|Phone||+61 3 6248 5800|
|Fax||+61 3 6248 4062|